×
News
April 4, 2014

Controlling Compliance Risk in Global Clinical Research Activities

Pharmaceutical Compliance Monitor

By Daniel A. Kracov Mahnu V. Davar
Find more content tagged:

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

People

Daniel A. Kracov
Daniel A. Kracov
Partner
Washington, DC
+1 202.942.5120
daniel.kracov@arnoldporter.com
VCard
Mahnu V. Davar
Mahnu V. Davar
Partner
Washington, DC
+1 202.942.6172
mahnu.davar@arnoldporter.com
VCard

Related Articles

December 23, 2019
Questions & Answers Guide to FDA’s Prescription Drug Importation Proposals
Advisory
December 19, 2019
EMA Guidance on Comparability Exercise for ATMPs
BioSlice Blog

Email Disclaimer

Reject Accept